


Lysaker, June 8 2015 - The primary insider and CEO, Per Walday, has purchased
3 500 shares at a price of NOK 6.62 per share. After this the primary insider,
Per Walday, holds a total of 44 019 shares and 126 000 unexercised options in
the company, corresponding to 80 000 unexercised options at a strike price of
NOK 14.07, 16 000 unexercised options at a strike price of NOK 27.38 and 30 000
unexercised options at a strike price of NOK 27.54 in the company.

The primary insider and CFO, Ronny Skuggedal, has purchased 5 000 shares at a
price of NOK 6.62 per share. After this the primary insider, Ronny Skuggedal,
holds a total of 15 000 shares and 60 000 unexercised options in the company,
corresponding to 40 000 unexercised options at a strike price of NOK 13.78 and
20 000 unexercised options at a strike price of NOK 12.53.

The primary insider and CSO, Anders Høgset, has purchased 1 500 shares at a
price of NOK 6.62 per share. After this the primary insider, Anders Høgset,
holds a total of 47 977 shares and 91 000 unexercised options in the company,
corresponding to 60 000 unexercised options at a strike price of NOK
14.07, 11 000 unexercised options at a strike price of NOK 27.38 and 20 000
unexercised options at a strike price of NOK 27.54.

For further information, please contact
Ronny Skuggedal, CFO
Mobile: +47 94005757
rs@pcibiotech.no

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.


[HUG#1926783] 
    